Matthias Preusser, MD
Medical University of Vienna, Vienna General Hospital (Austria) · Medical University of Vienna, Vienna General Hospital, Vienna, Austria · Medical Oncologist. Head of Clinical Division of Oncology, Medical University of Vienna
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Matthias Preusser, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06676917 · Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain MetastasesMedSIR · withdrawn · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT06048718 · T-DXd Therapy for HER2-low Breast Cancer Patients With Brain MetastasesMedSIR · active not recruiting · Breast Cancer, Metastatic Breast Cancer · principal investigator
- Ph2NCT05865990 · HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal DiseaseMedSIR · completed · Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult · principal investigator
- Ph2NCT02779101 · Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)Prof. Dr. Matthias Preusser · unknown · Primary Central Nervous System Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.